GDUFA Research Outcomes
Peptide APIs
This section contains scientific publications, presentations, and posters arising from GDUFA-funded research relevant to complex active pharmaceutical ingredients that are peptides, including associated impurities in generic products.
-
Follow up Discussion on FDA Peptide Guidance after Public Comments
Jiang, Jeff
-
Current Thinking on Synthetic Peptides in Abbreviated New Drug Applications
Jiang, Jeff
-
Challenges and Opportunities for Innovation in Complex Generic Drug Product Development
Jiang, Jeff
-
Introduction to complex products and FDA considerations
Jiang, Jeff
-
Considerations for Abbreviated New Drug Application of Generic Peptide Drug Products
Zhang, Deyi
-
In-Vitro Assessment of Comparative Immunogenicity for Generic Synthetic Peptide Drug Products
Pang, Eric; Liao, Kuo-Tang; Holley, Claire K; Dobrovolskaia, Marina A; Verthelyi, Daniela
-
Evaluation of Quantitative Capsule Rupture Test Methods and Data Variability in Generic Omega-3 Capsule Applications
Liu, Hao; Suh, Min Sung; Kozak, Darby; Pang, Eric
-
Scientific Considerations for Synthetic Peptides Referencing Peptide Drugs of rDNA Origin
Hu, Ping; Zhang, Deyi; Kozak, Darby; Jiang, Xiaohui